We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$4.32B
AUM Growth
-$159M
Cap. Flow
-$268M
Cap. Flow %
-6.19%
Top 10 Hldgs %
53.32%
Holding
157
New
15
Increased
45
Reduced
34
Closed
12

Top Buys

Rank Stock Value
1
ZTO icon
ZTO Express
ZTO
+$152M
2
ICE icon
Intercontinental Exchange
ICE
+$64.9M
3
TAL icon
TAL Education Group
TAL
+$58M
4
B
Barrick Mining
B
+$42.5M
5
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$42.3M

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$203M
2
FCX icon
Freeport-McMoran
FCX
+$106M
3
ALLY icon
Ally Financial
ALLY
+$84.9M
4
FDX icon
FedEx
FDX
+$78.3M
5
LPX icon
Louisiana-Pacific
LPX
+$59.7M

Sector Composition

Rank Sector Weight
1 Industrials 23.93%
2 Consumer Discretionary 20.51%
3 Technology 19.89%
4 Materials 10.93%
5 Healthcare 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTLA icon
76
Intellia Therapeutics
NTLA
$1.67B
$3.43M 0.08%
21,157
-16,068
-43% -$1.25M
ACIU icon
77
AC Immune
ACIU
$240M
$3.39M 0.08%
+427,536
New +$2.95M
ORTX
78
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$3.3M 0.08%
75,211
+12,614
+20% +$703K
DNTH icon
79
Dianthus Therapeutics
DNTH
$6.09B
$3.14M 0.07%
20,044
– –
AGIO icon
80
Agios Pharmaceuticals
AGIO
$1.93B
$3.12M 0.07%
56,593
– –
ASLN
81
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$2.93M 0.07%
22,172
+9,297
+72% +$1.16M
RBLX icon
82
Roblox
RBLX
$27B
$2.92M 0.07%
32,504
+26,542
+445% +$2.13M
SU icon
83
Suncor Energy
SU
$70.3B
$2.89M 0.07%
+120,525
New +$2.76M
BCEL
84
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$2.7M 0.06%
317,017
+173,743
+121% +$1.78M
BCRX icon
85
BioCryst Pharmaceuticals
BCRX
$2.4B
$2.67M 0.06%
168,715
– –
SGMO
86
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.61M 0.06%
218,336
– –
DNLI icon
87
Denali Therapeutics
DNLI
$3.97B
$2.42M 0.06%
30,791
– –
ADPT icon
88
Adaptive Biotechnologies
ADPT
$3.97B
$2.41M 0.06%
58,890
+13,058
+28% +$508K
BPMC
89
DELISTED
Blueprint Medicines
BPMC
$2.39M 0.06%
27,121
– –
LIVN icon
90
LivaNova
LIVN
$4.2B
$2.33M 0.05%
27,745
– –
INFO
91
DELISTED
IHS Markit Ltd. Common Shares
INFO
$2.19M 0.05%
19,460
-5,200
-21% -$552K
RCUS icon
92
Arcus Biosciences
RCUS
$3.64B
$2.07M 0.05%
75,290
– –
ORCL icon
93
Oracle
ORCL
$423B
$2.01M 0.05%
25,784
-6,436
-20% -$504K
MASS icon
94
908 Devices
MASS
$364M
$1.91M 0.04%
49,160
+15,580
+46% +$706K
CSCO icon
95
Cisco
CSCO
$479B
$1.89M 0.04%
35,700
– –
ELUT icon
96
Elutia
ELUT
$37.6M
$1.88M 0.04%
195,809
+54,414
+38% +$628K
AAPL icon
97
Apple
AAPL
$4.57T
$1.75M 0.04%
12,788
– –
XLRN
98
DELISTED
Acceleron Pharma
XLRN
$1.74M 0.04%
13,872
– –
X
99
DELISTED
US Steel
X
$1.73M 0.04%
+71,936
New +$1.77M
ALEC icon
100
Alector
ALEC
$199M
$1.66M 0.04%
79,884
+23,644
+42% +$446K
2 3
4
5 6

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Platinum Investment Management held 157 positions worth $4.32B, down 3.5% from $4.48B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Platinum Investment Management withdrew a net $268M in Q2 2021, closing 12 positions and reducing 34 holdings. Its most notable exit was Five Prime Therapeutics, Inc., an estimated $6.89M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Platinum Investment Management opened a new position in TAL Education Group worth $32.7M.

  • Platinum Investment Management's largest Q2 2021 buy was TAL Education Group: 1,297,317 shares worth $32.7M.
  • Platinum Investment Management added most to ZTO Express in Q2 2021, an estimated $152M increase.
  • Platinum Investment Management's biggest Q2 2021 reduction was GE Aerospace, cutting an estimated $203M.
  • Platinum Investment Management fully exited Five Prime Therapeutics, Inc. in Q2 2021, selling an estimated $6.89M.
  • Platinum Investment Management's ten largest holdings make up 53% of its $4.32B portfolio in Q2 2021.
  • Platinum Investment Management opened 15 new positions and closed 12 in Q2 2021.
  • Platinum Investment Management's portfolio value fell 3.5% quarter-over-quarter to $4.32B.

Based on Platinum Investment Management's 13F filing for Q2 2021, filed 11 Aug 2021.